A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)

Clinical trial NCT03398005 · COMPLETED

Trial details

NCT number: NCT03398005
Sponsor: Grace Therapeutics Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertriglyceridemia

Start date: 2018-01-23
Primary completion: 2019-07-21
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.